Edgewise Therapeutics Inc (EWTX)

36.37 +0.94 (+2.65%) USD  |  NASDAQ  |  Nov 08, 13:05
More

Edgewise Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Catalyst Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc Upgrade
Regenxbio Inc Upgrade
Entrada Therapeutics Inc Upgrade